Podcasts about tackling tb

India faces a silent health crisis: tuberculosis (TB) and lung diseases. TB alone claims 3,500 lives every day, making it the world's second leading cause of death from a single infectious agent, surpassed only by COVID-19. With rising air pollution and tobacco use, the burden of lung diseases continues to grow. However, amidst these daunting challenges, there is hope. In this episode, we are joined by Nidhi Bansal, the Country Director for The Union India Office. The Union, a global organization at the forefront of fighting TB and lung disease, is driving impactful change through research, advocacy, and community engagement. Nidhi brings decades of experience tackling complex health crises worldwide, and in this candid conversation, she shares her insights, experiences, and vision for a healthier India. Join us as we delve into the unique challenges, inspiring success stories, and the road ahead in the fight against TB and lung disease. Discussion Highlights: India's Unique Challenges in Tackling TB and Lung Disease: What sets India apart in this fight, and what are the key obstacles? Stories of Impact: A powerful example of how The Union's multi-faceted approach has transformed lives. Breaking the Stigma: The role of public figures like Amitabh Bachchan in raising awareness and how more voices can join the cause. The 2030 Goal: Can we truly end TB by 2030? What will it take to achieve this ambitious target? Hope and Innovation: The most promising advancements and initiatives offering a ray of hope in combating TB and lung diseases. Tune in for an eye-opening conversation with Nidhi Bansal as we explore the critical work being done to turn the tide against this pressing health crisis. If your organisation is dedicated to driving positive social change, we want to hear from you. Reach out to us at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Good Sight⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ by emailing us at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠contact@thegoodsight.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ with a brief description of your work and achievements, or give us a call at 9696399931.

Summary: We dive into the complexities of navigating the US healthcare system with insights from Franky and Mohammad, focusing specifically on the Marshallese community's challenges and the widespread misconceptions about TB screenings in diverse populations. Together, we explore culturally responsive strategies to improve trust and treatment adherence, including employing trusted community messengers, understanding patient education needs, and addressing the nonclinical aspects of care. Our discussions underscore the necessity of patient-centered communication, acknowledging cultural beliefs and practices in treatment, and the critical role of community navigators in facilitating accessible healthcare. By acknowledging these crucial factors, we aim to foster a deeper understanding of and responsiveness to the unique healthcare needs within various communities. Timestamped Overview: 02:04 Addressing the complexity of the US healthcare system and the Marshallese community's challenges. 07:15 Tackling TB misconceptions and the impact on screenings within diverse populations. 13:30 Importance of culturally responsive care and trusted community messengers in healthcare. 17:48 Strategies for medical professionals to build trust and set proper expectations for patient care. 22:27 Role of community navigators in facilitating healthcare access and understanding. 27:35 Utilizing metaphors and visual aids for effective communication about latent TB. 32:42 Balancing respect for patients' decisions while advocating for preventive care. 37:50 Overcoming cultural and literacy barriers with diverse educational materials. 42:57 Emphasizing a collective family approach to healthcare in community engagement. 47:11 Discussing latent TB's prevalence, risks, and the necessity of screening and treatment. Next Step: Visit our website, Healthcare for Humans, and join our community to enjoy exclusive benefits at https://www.healthcareforhumans.org/support/ Earn CME Credits: Clinicians, enhance your learning by earning valuable continuing education credits while listening. Utilize your CME funds to join our community. Support Our Mission: Non-clinicians, explore exclusive content and contribute to our collective journey. Be an Active Participant: Go beyond listening. Shape our narrative by co-creating episodes with us. Be part of our community by visiting https://www.healthcareforhumans.org/support/. Follow us on Instagram @healthcareforhumanspodcast Sponsored by: Public Health – Seattle & King County TB Clinic

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Carlos Jesus Acuña-Villaorduña, MD What are some of the immunologic mechanisms that alter our ability to fight off a mycobacterium tuberculosis infection—and how does this affect our immunocompromised patients? To answer this question, Dr. Charles Turck meets with Dr. Carlos Acuña-Villaorduña from the Boston University School of Medicine to discuss new insights on TB infection and immunosuppression.

Guest: Pranay Sinha, MD Where are we on the path to eliminating tuberculosis? To understand this, Dr. Pranay Sinha, a postdoctoral researcher at Boston Medical Center, discusses what we need to know and shares what's on the horizon for TB elimination.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jeffrey D. Cirillo, PhD How prevalent is tuberculosis in long-term care facilities? To better understand this, Dr. Charles Turck meets with Dr. Jeffrey Cirillo to examine screening and testing strategies to better monitor TB risk, specifically for high-risk patient populations.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Laila Woc-Colburn, MD, DTM&H, FACP, FIDSA What are some ways we can better care for our patients prior to starting biologic therapy? Dr. Charles Turck joins Dr. Laila Woc-Colburn from the Emory University School of Medicine to discuss ways to improve safety for patients with tuberculosis.

In this episode our hosts Ami Sawran and Claire Whittle are joined by Sarah Tomlinson from VetPartners. Sarah talks with us about the importance of managing and dealing with TB, particularly through the TB Advisory Service (TBAS). She talks about how specialising in TB has shaped her career, balancing veterinary practice with being a Mum and challenges what is meant by a ‘proper farm vet'. Don't forget to like and subscribe, and get involved by sharing your 'vetspective' on our social media channels.

In this episode our hosts Ami Sawran and Claire Whittle are joined by Sarah Tomlinson from VetPartners. Sarah talks with us about the importance of managing and dealing with TB, particularly through the TB Advisory Service (TBAS). She talks about how specialising in TB has shaped her career, balancing veterinary practice with being a Mum and challenges what is meant by a ‘proper farm vet'. Don't forget to like and subscribe, and get involved by sharing your 'vetspective' on our social media channels.

In this episode, three people from the Access Alliance join Andrea to talk about embedding community in research. In a recent research project done by the Access Alliance on the topic of tackling tuberculosis stigma, community was engaged at every step of the process. proejct Leads Shafeeq Armstrong and Jessica Kwan along with Knowledge. Mobilization and Social Action Coordinator Miranda Saroli each share about the project and what they learned from it. Read more about the project here. 

Guest: Jeffrey R. Starke, MD Host: Paul P. Doghramji, MD, FAAFP Dr. Paul Doghramji joins Dr. Jeffrey Starke, an Infection Control Officer at Texas Children's Hospital and a Professor of Pediatric Infectious Disease Medicine at Baylor College of Medicine, to discuss the impact that the COVID-19 pandemic has had on testing for tuberculosis.

Host: Paul Doghramji, MD Guest: Sarojini Qasba, MD With the World Health Organization’s goal to eliminate tuberculosis by 2030 quickly approaching, what can we be doing now to help us meet that goal? Joining Dr. Jennifer Caudle to discuss three key factors and how the COVID-19 pandemic has impacted this global goal is Dr. Sonia Qasba, an infectious disease specialist at the Suburban Hospital in Bethesda, Maryland.

Guest: Jeffrey D. Cirillo, PhD It’s critical that we understand whether or not a patient with an immune-mediated inflammatory disease has latent tuberculosis (TB) before starting treatment with inhibitory therapies as this can impact TB reactivation frequencies and the risk of complications. Dr. Jeffrey Cirillo from the Texas A&M College of Medicine explains how we can test for latent TB.

Guest: Marie-Claire Rowlinson, PhD, D(ABMM) The COVID-19 pandemic has pushed clinical laboratories to find new strategies to keep at-risk patients protected. When it comes to tuberculosis testing, what are some things laboratories are doing to ensure patient safety? Dr. Marie-Claire Rowlinson details some of these safety measures and discusses the pandemic’s impact on laboratory testing.

Host: Jennifer Caudle, DO Guest: Marie-Claire Rowlinson, PhD, D(ABMM) Guest: Regina McDade EdD, MPH, BSN, CIC, RN While annual tuberculosis rates have steadily declined for the general population, healthcare professionals have seen a rise in infection rates. What can we do to keep ourselves and our peers safe? Drs. Regina McDade and Marie-Claire Rowlinson discuss the updated guidelines for tuberculosis screening, or TB screening, among healthcare professionals.

Guest: Masae Kawamura, MD Host: Jennifer Caudle, DO What are some of the current roadblocks and innovations that are seen in our efforts to eradicate tuberculosis (TB)? Here to walk us through them is Dr. Masae Kawamura, practicing internist in San Francisco.

Host: Jennifer Caudle, DO Guest: Masae Kawamura, MD What’s it like to care for patients with tuberculosis (TB)? Here to share stories and reflections from her experience is Dr. Masae Kawamura, practicing internist in San Francisco.

Host: Jennifer Caudle, DO Guest: Lee Reichman, MD, MPH Even though tuberculosis (TB) is both curable and preventable, it continues to be a major public health issue across the world. That’s why Dr. Lee Reichman, Founding Executive Director of the Rutgers Global Tuberculosis Institute, is here to bring us up to speed on risk-based screening strategies for latent TB.

Guest: Masae Kawamura, MD Tuberculosis (TB) takes a life every 18 seconds…but you can play a part in putting a stop to the spread of this infectious disease by adopting screening best practices. Here to run down who and how you should screen for TB is Dr. Masae Kawamura, Qiagen’s Senior Director of Scientific and Medical Affairs.

Guest: Masae Kawamura, MD Tuberculosis (TB) takes a life every 18 seconds…but you can play a part in putting a stop to the spread of this infectious disease by adopting screening best practices. Here to run down who and how you should screen for TB is Dr. Masae Kawamura, Qiagen’s Senior Director of Scientific and Medical Affairs.

Guest: Masae Kawamura, MD Tuberculosis (TB) takes a life every 18 seconds…but you can play a part in putting a stop to the spread of this infectious disease by adopting screening best practices. Here to run down who and how you should screen for TB is Dr. Masae Kawamura, Qiagen’s Senior Director of Scientific and Medical Affairs.

Host: John J. Russell, MD Guest: Lee Reichman, MD, MPH To help us understand how primary care physicians can lead the way in proactively identifying and treating patients at high risk for TB, we caught up with Dr. Lee Reichman, Founding Executive Director of the Rutgers Global Tuberculosis Institute and Professor of Medicine and Epidemiology at Rutgers New Jersey Medical School.

Host: John J. Russell, MD Guest: Lee Reichman, MD, MPH To help us understand how primary care physicians can lead the way in proactively identifying and treating patients at high risk for TB, we caught up with Dr. Lee Reichman, Founding Executive Director of the Rutgers Global Tuberculosis Institute and Professor of Medicine and Epidemiology at Rutgers New Jersey Medical School.

Host: John J. Russell, MD Guest: Lee Reichman, MD, MPH To help us understand how primary care physicians can lead the way in proactively identifying and treating patients at high risk for TB, we caught up with Dr. Lee Reichman, Founding Executive Director of the Rutgers Global Tuberculosis Institute and Professor of Medicine and Epidemiology at Rutgers New Jersey Medical School.

Guest: Scott Lindquist, MD, MPH Primary care physicians play a critical role in eliminating TB, which is why they need to know who they should screen for TB and how. Join Dr. Scott Lindquist, state epidemiologist for communicable diseases and Deputy Health Officer for Washington State, as he explains the importance of risk-based TB screening and the testing methods that are appropriate for these patients.

Guest: Scott Lindquist, MD, MPH Primary care physicians play a critical role in eliminating TB, which is why they need to know who they should screen for TB and how. Join Dr. Scott Lindquist, state epidemiologist for communicable diseases and Deputy Health Officer for Washington State, as he explains the importance of risk-based TB screening and the testing methods that are appropriate for these patients.

Guest: Scott Lindquist, MD, MPH Primary care physicians play a critical role in eliminating TB, which is why they need to know who they should screen for TB and how. Join Dr. Scott Lindquist, state epidemiologist for communicable diseases and Deputy Health Officer for Washington State, as he explains the importance of risk-based TB screening and the testing methods that are appropriate for these patients.